Payden & Rygel’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-40,900
| Closed | -$18.8M | – | 133 |
|
|
2023
Q1 | $18.8M | Sell |
40,900
-27,000
| -40% | -$12.4M | 1.11% | 42 |
|
|
2022
Q4 | $34.8M | Buy |
67,900
+1,500
| +2% | +$769K | 1.86% | 13 |
|
|
2022
Q3 | $30.2M | Buy |
66,400
+27,200
| +69% | +$12.4M | 1.76% | 15 |
|
|
2022
Q2 | $18.9M | Buy |
39,200
+35,400
| +932% | +$17.1M | 1.14% | 43 |
|
|
2022
Q1 | $1.87M | Buy |
3,800
+1,900
| +100% | +$934K | 0.09% | 81 |
|
|
2021
Q4 | $881K | Sell |
1,900
-63,200
| -97% | -$29.3M | 0.04% | 97 |
|
|
2021
Q3 | $24.3M | Sell |
65,100
-200
| -0.3% | -$74.6K | 1.26% | 34 |
|
|
2021
Q2 | $24.9M | Buy |
65,300
+100
| +0.2% | +$38.2K | 1.19% | 42 |
|
|
2021
Q1 | $23.4M | Buy |
+65,200
| New | +$23.4M | 1.09% | 47 |
|